(TheNewswire)
Vancouver, British Columbia – TheNewswire - August 10 ,2021 - Gnomestar CraftInc. (CSE:GNOM ) , (CNSX:GNOM.CN), ( FSE:1JV1 ) , ( OTC:VDQSF)(“Gnomestar” or the “Company") is pleased announce it haspartnered with BOAZ Pharmaceuticals Inc. dba BOAZ Craft Cannabis(“BOAZ”) to provide its craft products through the BOAZ saleschannels.
BOAZ operates a state of the art 21,500 square facilitythat utilizes environmentally friendly grow pods – their mission isto grow the highest quality cannabis possible in an environmentallyfriendly way. Through the hard work of our team at Gnomestar, we areable to compliment the production of BOAZ and include ourselves in thesuite of offerings that meet the high standards of BOAZ - a top OCScertified craft cannabis producer.
Our 12,000 square foot facility continues to refine itsprocesses to improve upon our previous successes and this agreementrepresents a milestone on the path of recognition for our growers andtheir techniques. The first offering will be a select batch ofGnomestar’s 15 day hang dried, 45 day cold cured, hand trimmed RedCongolese. “We look forward to an exciting combination of qualityand effort that will strengthen our position in the market”, saidMark Lotz, CEO of Gnomestar.
This initial offering of Red Congolese will beavailable at retailers in Alberta, Saskatchewan, Manitoba, and Yukon,with a plan to bring addition unique strains to market in Q4 2021.
About BOAZ
BOAZ Craft Cannabis a privately owned company isemerging as one of Canada’s most exciting producers and processorsof Certified Craft Cannabis (OCS). Based in Calgary, Alberta, the BOAZbrand is synonymous with high quality products, with connoisseursraving about the overall quality of BOAZ’s products, highlighting,among other things, the flavor/taste profile, smell, andintensity.
For further information pleasecontact:
David Isaak, Chief Executive Officer and President
BOAZ Pharmaceuticals Inc. dba BOAZ CraftCannabis
Email: disaak@boazpharm.com
About Gnomestar
For further information pleasecontact:
Mark Lotz, Chief Executive Officer and CFO
Vodis Pharmaceuticals Inc.
Email: mark@vodis.ca
NOT FOR DISSEMINATION IN THE UNITEDSTATES OR THROUGH UNITED STATES NEWSWIRE SERVICES
Neither the Canadian Securities Exchange nor itsregulation services provider accepts responsibility for the adequacyor accuracy of this release. No stock exchange, securities commissionor other regulatory authority has approved or disapproved theinformation contained herein.
Forward-LookingInformation : This news release contains“forward-looking information” within the meaning of applicablesecurities laws including statements relating to the outlook of thebusiness of the Company, the planned expenditures for upgrades andother renovations at the Company’s facilities in Delta, BC. Althoughthe Company believes considering the experience of its officers anddirectors, current conditions and expected future developments andother factors that have been considered appropriate, that theexpectations reflected in this forward-looking information arereasonable, undue reliance should not be placed on them as the Companycan give no assurance that they will prove to be correct. Actualresults and developments may differ materially from those contemplatedby these statements, depending on, among other things, the risks thatthe private placement financings may not close for any reason(including the failure to obtain the required approvals or clearancesfrom regulatory authorities) or that the terms of the privateplacement financing may differ from those that currently arecontemplated. The statements in this news release are made as of thedate of this release. The Company is under no obligation, andexpressly disclaims any intention or obligation, to update or reviseany forward-looking statements, whether as a result of newinformation, future events or otherwise, except as expressly requiredby applicable law.
Copyright (c) 2021 TheNewswire - All rights reserved.